We are live on ! Find out more
Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘23
301
5 20 15 75.6%
302
5 7 2 9.88%
303
5 41 36 31.6%
IKT icon
304
Inhibikase Therapeutics
IKT
$220M
5 8 3 20.1%
305
5 6 1 33.4%
306
5 7 2 6.31%
307
5 7 2 81.8%
308
5 19 14 59.7%
309
5 19 14 15.6%
310
5 14 9 58.6%
SCLX icon
311
Scilex Holding
SCLX
$49.5M
5 18 13 85.6%
312
5 6 1 96%
313
5 5 0 0.92%
314
5 11 6 61%
315
5 6 1 44.8%
316
5 6 1 6.4%
317
5 7 2 60.3%
318
5 19 14 66.5%
319
5 20 15 37.2%
320
5 27 22 21%
321
5 8 3 80.6%
322
5 11 6 2.88%
323
5 9 4 14%
324
5 16 11 68.8%
325
5 9 4 56.8%